CLINICAL EVALUATION OF PSYCHOTHERAPEUTIC MEDICATIONS

NIH GUIDE, Volume 22, Number 25, July 16, 1993



RFP AVAILABLE:  NIMH-OP-93-0007



P.T. 34



Keywords:

  Psychotherapy 

  Pharmaceuticals 

  Clinical Trial 



National Institute of Mental Health



The purpose of this procurement is to conduct Phase I and Phase II

clinical trials of compounds to evaluate their utility as new and

effective psychotherapeutic medications.  The contractor must have

the capability to plan the clinical development of an investigational

compound, design and develop protocol, provide clinical trial sites,

monitor clinical studies to Good Clinical Practice standards, manage

data acquisition, and prepare quality written final summary reports

in support of a NDA submission.  A twenty-eight month cost

reimbursement type contract with three one-year options is

anticipated.  This announcement appeared in the Commerce Business

Daily April 29, 1993.  Persons who responded to the Commerce Business

Daily announcement are already on the mailing list for RFP No.

NIMH-OP-93-0007 and are not required to respond to this notice.  The

RFP is scheduled for issuance on or about July 1, 1993 and will close

approximately 60 calendar days thereafter.



INQUIRIES



All requests must be made in writing or by FAX to:



LouEllen M. Rice, Contracting Officer

Contracts Management Branch

Parklawn Building, Room 7C-18

5600 Fishers Lane

Rockville, MD  20857

Telephone:  (301) 443-2696

FAX:  (301) 443-6885



Telephone requests will not be honored.



.

Return to 1993 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)